CardioNerds SCAI

Welcome to the CardioNerds at SCAI SHOCK 2022 Knowledge Hub, powered by CardioNerds. We’ll deliver in-depth video interviews with key opinion leaders in the cardiology space, featuring the latest data on enhancing multidisciplinary care in cardiogenic shock and highlights from the 2022 conference, taking place October 13-15 in Minneapolis, Minnesota.

Featured Videos

CardioNerds at SCAI SHOCK 2022: The RECOVER IV Trial

video
The RECOVER IV trial is a two-arm study that seeks to analyze whether percutaneous coronary intervention (PCI) with Impella® heart pumps used prior to PCI is superior to PCI without Impella support. In this video interview, Drs. Nick Smith (Johns Hopkins Hospital) and Gurleen Kaur...

CardioNerds at SCAI SHOCK 2022: CAPITAL DOREMI 2

video
The CAPITAL DOREMI 2 study is a multi-centre, double-blind, randomized controlled trial which assessed the safety and efficacy of inotrope therapy versus placebo in treating patients with SCAI class C to D cardiogenic shock. In this video interview, Drs. Nick Smith (Johns Hopkins Hospital) and...

CardioNerds at SCAI SHOCK 2022: The DanGer Shock Trial

video
The recent DanGer Shock trial sought to assess if the use of left ventricular mechanical circulatory support using Impella CP transvalvular microaxial flow pump enhances survival in patients with cardiogenic shock. In this interview, Drs. Nazli Okumus and Saahil Jumkhawala of the CardioNerds spoke with...

CardioNerds at SCAI SHOCK 2022: The PACCS Trial

PA-Catheter in Cardiogenic Shock (PACCS)video
The Pulmonary Artery Catheter in Cardiogenic Shock Trial (PACCS) was conducted to analyze if early invasive hemodynamic assessment and ongoing management with a PAC in cardiogenic shock patients is associated with lower in-hospital mortality compared to standard of care. In this interview, Drs. Nick Smith...

CardioNerds at SCAI SHOCK 2022: The VANQUISH Shock Registry

VANQUISH Shock Registryvideo
Despite advances in treatment, cardiogenic shock (CS) outcomes remain dire. As such, researchers initiated the Multicenter Collaborative to Enhance Biological Understanding, Quality and Outcomes in Cardiogenic Shock registry (VANQUISH Shock), which aims to assess unrestricted adult patients with CS at several North American centers. In...

Upcoming SCAI SHOCK 2022 Highlights

SCAI Shock National Cardiogenic Shock Initiative
SCAI SHOCK America vs Europe in Cardiogenic Shock
SCAI SHOCK Cardiogenic Shock Working Group Registry
SCAI SHOCK CVAD Shock
SCAI SHOCK ISO-Shock Trial

Meet The NERDS!

Advertisement
Advertisement

More from CardioNerds